These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy. Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791 [TBL] [Abstract][Full Text] [Related]
23. Glioblastoma: patterns of recurrence and efficacy of salvage treatments. Oh J; Sahgal A; Sanghera P; Tsao MN; Davey P; Lam K; Symons S; Aviv R; Perry JR Can J Neurol Sci; 2011 Jul; 38(4):621-5. PubMed ID: 21672702 [TBL] [Abstract][Full Text] [Related]
24. Treatment of newly diagnosed malignant glioma in the elderly people: new trials that impact therapy. Chamberlain MC Int J Clin Pract; 2013 Dec; 67(12):1225-7. PubMed ID: 24246204 [TBL] [Abstract][Full Text] [Related]
25. Treatment Outcome in Patients with Primary Central Nervous System Germ Cell Tumour: Clinical Experience from a Regional Cancer Centre in North India. Biswas A; Julka PK; Bakhshi S; Singh M; Rath GK Pediatr Neurosurg; 2017; 52(4):240-249. PubMed ID: 28538229 [TBL] [Abstract][Full Text] [Related]
26. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma. Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646 [TBL] [Abstract][Full Text] [Related]
27. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy. Damodaran O; van Heerden J; Nowak AK; Bynevelt M; McDonald K; Marsh J; Lee G J Clin Neurosci; 2014 Mar; 21(3):478-81. PubMed ID: 24332268 [TBL] [Abstract][Full Text] [Related]
28. Can elderly patients with newly diagnosed glioblastoma be enrolled in radiochemotherapy trials? Fiorentino A; Balducci M; De Bonis P; Chiesa S; De Filippo L; Mangiola A; De Rose F; Autorino R; Rinaldi C; Fersino S; Diletto B; Matteucci P; Ciurlia E; Fusco V; Anile C; Valentini V Am J Clin Oncol; 2015 Feb; 38(1):23-7. PubMed ID: 23388566 [TBL] [Abstract][Full Text] [Related]
29. Survival outcomes of giant cell glioblastoma: institutional experience in the management of 20 patients. Oh T; Rutkowski MJ; Safaee M; Sun MZ; Sayegh ET; Bloch O; Tihan T; Parsa AT J Clin Neurosci; 2014 Dec; 21(12):2129-34. PubMed ID: 25037316 [TBL] [Abstract][Full Text] [Related]
30. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342 [TBL] [Abstract][Full Text] [Related]
31. Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis. Gutenberg A; Bock HC; Reifenberger G; Brück W; Giese A Acta Neurochir (Wien); 2013 Mar; 155(3):429-35. PubMed ID: 23254891 [TBL] [Abstract][Full Text] [Related]
32. Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death. Wasserfallen JB; Ostermann S; Pica A; Mirimanoff RO; Leyvraz S; Villemure JG; Stupp R Cancer; 2004 Nov; 101(9):2098-105. PubMed ID: 15389472 [TBL] [Abstract][Full Text] [Related]
33. Combined modality treatment of newly diagnosed glioblastoma multiforme in a regional neurosurgical centre. Gauden AJ; Hunn A; Erasmus A; Waites P; Dubey A; Gauden SJ J Clin Neurosci; 2009 Sep; 16(9):1174-9. PubMed ID: 19540125 [TBL] [Abstract][Full Text] [Related]
34. Pseudoprogression in patients with glioblastoma multiforme after concurrent radiotherapy and temozolomide. Topkan E; Topuk S; Oymak E; Parlak C; Pehlivan B Am J Clin Oncol; 2012 Jun; 35(3):284-9. PubMed ID: 21399487 [TBL] [Abstract][Full Text] [Related]
35. Post-operative management of primary glioblastoma multiforme in patients over 60 years of age. Daróczi B; Szántó E; Tóth J; Barzó P; Bognár L; Bakó G; Szántó J; Mózes P; Hideghéty K Ideggyogy Sz; 2013 Nov; 66(11-12):391-8. PubMed ID: 24555238 [TBL] [Abstract][Full Text] [Related]
36. Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis. Minniti G; Scaringi C; Lanzetta G; Terrenato I; Esposito V; Arcella A; Pace A; Giangaspero F; Bozzao A; Enrici RM Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):109-15. PubMed ID: 25442339 [TBL] [Abstract][Full Text] [Related]
37. Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Minniti G; Lanzetta G; Scaringi C; Caporello P; Salvati M; Arcella A; De Sanctis V; Giangaspero F; Enrici RM Int J Radiat Oncol Biol Phys; 2012 May; 83(1):93-9. PubMed ID: 22079725 [TBL] [Abstract][Full Text] [Related]